Gray M M, Hann I M, Glass S, Eden O B, Jones P M, Stevens R F
Br Med J (Clin Res Ed). 1987 Jul 4;295(6589):19-22. doi: 10.1136/bmj.295.6589.19.
Measles is a major cause of mortality and morbidity in children receiving treatment for leukaemia. A review was made of all the documented cases of measles in children in first remission from acute lymphoblastic leukaemia at four major treatment centres in 1974-84. Over the 11 years reviewed 1043 children with acute lymphoblastic leukaemia were referred to these centres. Fifty one (4.9%) died while in first remission and 15 (29.4%) of these deaths were due to measles or its complications: 12 cases of pneumonia, 10 of them fatal; and six cases of encephalitis, five of them fatal and the sixth child left severely handicapped. These children would have had at least a 50% chance of long term survival. The severity of measles in the immunocompromised patient reinforces the need to improve the poor uptake of measles immunisation in Britain.
麻疹是接受白血病治疗的儿童死亡和发病的主要原因。对1974年至1984年期间四个主要治疗中心急性淋巴细胞白血病首次缓解期儿童的所有麻疹记录病例进行了回顾。在回顾的11年中,1043名急性淋巴细胞白血病儿童被转诊到这些中心。51名(4.9%)在首次缓解期死亡,其中15名(29.4%)死亡是由于麻疹或其并发症:12例肺炎,其中10例致命;6例脑炎,其中5例致命,第六名儿童严重残疾。这些儿童本来至少有50%的长期存活机会。免疫功能低下患者中麻疹的严重性凸显了改善英国麻疹疫苗接种率低的必要性。